Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

China flag China · Delayed Price · Currency is CNY
41.86
-0.32 (-0.76%)
At close: Feb 6, 2026
-38.38%
Market Cap52.93B -38.4%
Revenue (ttm)1.80B -27.9%
Net Income-333.84M
EPS-0.26
Shares Out1.26B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,878,131
Average Volume5,376,193
Open42.07
Previous Close42.18
Day's Range41.77 - 42.13
52-Week Range41.31 - 80.00
Beta1.07
RSI34.86
Earnings DateApr 21, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells in vitro diagnostic reagents and instruments, and vaccines in China and internationally. It operates through Diagnostics Division and Vaccine Division segments. The company offers chemiluminescence detection, biochemical, hepatitis B core antibody detection, and HIV reagents; rapid urine tests for hepatitis E antigen; chronic disease management, hepatitis E screening and prevention, women’s full life-cycle health management, smart laboratories, medic... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 3,790
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603392
Full Company Profile

Financial Performance

In 2024, SHA:603392's revenue was 2.25 billion, a decrease of -59.25% compared to the previous year's 5.51 billion. Earnings were 106.24 million, a decrease of -91.49%.

Financial Statements